Search hospitals > Michigan > Battle Creek

Bronson Battle Creek

Claim this profile
Battle Creek, Michigan 49017
Global Leader in Skin Cancer
Global Leader in Breast Cancer
Conducts research for Stomach Cancer
Conducts research for Lung Cancer
Conducts research for Relapse
271 reported clinical trials
1 medical researcher
Photo of Bronson Battle Creek in Battle CreekPhoto of Bronson Battle Creek in Battle CreekPhoto of Bronson Battle Creek in Battle Creek

Summary

Bronson Battle Creek is a medical facility located in Battle Creek, Michigan. This center is recognized for care of Skin Cancer, Breast Cancer, Stomach Cancer, Lung Cancer, Relapse and other specialties. Bronson Battle Creek is involved with conducting 271 clinical trials across 443 conditions. There are 1 research doctors associated with this hospital, such as Kathleen J. Yost.

Area of expertise

1Skin Cancer
Global Leader
Bronson Battle Creek has run 122 trials for Skin Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage I
2Breast Cancer
Global Leader
Bronson Battle Creek has run 46 trials for Breast Cancer. Some of their research focus areas include:
HER2 negative
ER positive
Stage IV

Top PIs

Clinical Trials running at Bronson Battle Creek

Breast Cancer
Skin Cancer
Breast cancer
Bladder Cancer
Lung Cancer
Ovarian Cancer
Cancer
Non-Small Cell Lung Cancer
Cutaneous Melanoma
Multiple Myeloma
Image of trial facility.

Chemotherapy + Hormone Therapy

for Breast Cancer

This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Radiation and HER2-Targeted Therapy

for Breast Cancer

This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Image of trial facility.

Carvedilol

for Preventing Heart Problems in HER2 Positive Breast Cancer

This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Bronson Battle Creek?
Bronson Battle Creek is a medical facility located in Battle Creek, Michigan. This center is recognized for care of Skin Cancer, Breast Cancer, Stomach Cancer, Lung Cancer, Relapse and other specialties. Bronson Battle Creek is involved with conducting 271 clinical trials across 443 conditions. There are 1 research doctors associated with this hospital, such as Kathleen J. Yost.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security